NCT06831370 A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India Status RECRUITING Phase PHASE4
NCT06761599 Frequency of Pulmonary Toxicity in Patients Treated for Hodgkin Lymphoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06744075 Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT06733987 Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma Status RECRUITING Phase N/A
NCT06564259 Relationship Between Serum β2-Microglobulin and Infiltration of CD8+ in the Tumor Tissue of Hodgkin's Lymphoma Patients Status COMPLETED Phase N/A
NCT06550427 Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing Status RECRUITING Phase N/A
NCT06521567 A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06398457 Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies Status RECRUITING Phase EARLY_PHASE1
NCT06383338 A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. Status RECRUITING Phase PHASE1
NCT06295211 Brentuximab Vedotin Combined With Bendamustine Supercharge, a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma: Long-term Results of a Retrospective Monocenter Study. Status COMPLETED Phase N/A
NCT06201507 BV-AVD-R Treatment Children Hodgkin's Lymphoma Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06176690 Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas Status RECRUITING Phase PHASE1
NCT06170489 A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL) Status RECRUITING Phase PHASE3
NCT06150664 A Phase 1 of CTX-8371 in Patients With Advanced Malignancies Status RECRUITING Phase PHASE1
NCT06137144 AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. Status RECRUITING Phase PHASE1/PHASE2